FDA Drafts New Guidance for the Development of Affordable Biosimilar Drugs

The new guidance seeks to lower development costs and improve patient access to safe, effective alternatives to high-cost biologic medicines. The U.S. Food and Drug Administration (FDA) recently…

Read More

FDA Launches Voucher Program to Accelerate Priority Review of Drugs

Nine products selected under the pilot initiative are intended to address major health needs and boost U.S. manufacturing. The U.S. Food and Drug Administration has recently named nine…

Read More

FDA Approves Drug for New World Screwworm in U.S. Livestock

Dectomax-CA1 receives conditional approval to help protect livestock from a serious parasitic threat while data collection continues. The U.S. Food and Drug Administration (FDA) has conditionally approved Dectomax-CA1…

Read More

President Announces TrumpRx Medication Program

He stated that purchasing from manufacturers directly will reduce prices. President Donald Trump announced a new program called TrumpRx this week under his Most Favored Nation (MFN) initiative,…

Read More

FDA Begins Daily Updates of Adverse Drug Event Reports

The new reporting schedule is intended to improve transparency and speed in detecting safety concerns. The Food and Drug Administration has started publishing daily updates from the FDA…

Read More

FDA Approves Ketamine Product for Surgical Pain Management

The agency says the psychedelic drug shows promise despite addictiveness and short supply. The Food and Drug Administration (FDA) approved a new ketamine-based drug called KETARx for use…

Read More

FDA and USDA Propose Regulation Change for Orange Juice

The goal is to benefit U.S. citrus growers and reduce the reliance on foreign oranges for juice production. The U.S. Department of Agriculture (USDA) and the Food and…

Read More

FDA Updates Opioid Labels to Emphasize Long-Term Risks

New labeling rules follow evidence linking extended opioid use to serious health dangers, including addiction and overdose. The U.S. Food and Drug Administration (FDA) has mandated updated safety…

Read More

Federal Agencies Move to Define Ultra-Processed Foods

HHS and USDA launch joint initiative to address chronic disease by standardizing food labeling and improving consumer transparency. The U.S. Department of Health and Human Services (HHS) and…

Read More

FDA Commissioner Commits to Full Review of Abortion Pill

He responded to a request from Senator Hawley that highlighted new research on the dangers of mifepristone. Food and Drug Administration Commissioner Marty Makary has committed his agency…

Read More

Back to top
FE3